课题基金 / 基金详情

Mitochondria and Mustard Damage at the Ocular Surface

Mitochondria and Mustard Damage at the Ocular Surface
眼表的线粒体和芥末损伤
批准号:
10708498
负责人:
M. Elizabeth Fini
金额:
$53.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31

项目摘要

项目成果

M. Elizabeth Fini的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Ocular surface (OcS) exposure to the chemical warfare vesicant sulfur mustard (SM), or its analogue nitrogen mustard (NM), causes immediate tissue damage and long-term pathology. Current medical countermeasures (MCMs) frequently result in incomplete or transient efficacy. Excessive accumulation of reactive oxygen species (ROS) induces oxidative stress (OXS), which plays prominently in OcS epithelial damage from a variety of causes, including exposure to SM and analogues. ROS are produced by mitochondria. It is known that mitochondria are damaged by exposure to SM analogues, but mechanisms leading to OXS are under- explored. Recently, the project team made the unexpected discovery that dynasore and dyngo-4a, small molecules that target dynamin family proteins involved in mitochondrial homeostasis, are remarkably protective against OXS due to hydrogen peroxide (HP) exposure in an OcS epithelial cell culture model. In a follow-up study, they identified a novel pathway whereby dynasore protects by inhibiting Ca2+ influx, shifting activity of the unfolded protein response (UPR) towards homeostasis and inhibiting mitochondrial transition pore (mPTP) opening. In Preliminary Data presented herein, they now show that NM exposure also induces the UPR in the cell culture model, but dynasore is not protective. Interestingly, another small molecule inhibitor of dynamins is protective: mdivi-1. Signficantly, mdivi-1 did not shift the UPR towards homeostasis in NM-exposed cells and did not protect against HP exposure. These results indicate that mechanisms leading to OXS after exposure to HP or NM must be different, and that elucidating the mechanism of mDivi-1 counteraction may provide important insight into how NM damages cells. Mdivi-1 has been widely considered to be a specific inhibitor of the mitochondrial-localized dynamin DRP1. However, it was recently reported that mdivi-1 also directly targets mitochondrial energetics. The objective of this project is to investigate mitochondrial mechanisms in OcS exposure to NM, the relationship to HP exposure, and mechanisms of OcS protection by mdivi-1. The team will employ a well-established human corneal epithelial cell culture model. To ensure scientific rigor, primary human corneal epithelial cells will be used to validate key results in vitro, and a mouse model will provide in vivo validation. To add an innovative dimension, live cell evaluative methods and discovery techniques will be applied, including Ca2+ imaging, mitochondrial imaging, cell-based reporter constructs, transgenic reporter mice, RNA-seq and single cell RNA-seq (scRNA-seq). Results of the planned study will provide new knowledge about how NM exposure leads to OXS. Mdivi-1 has the unusual capacity to attenuate pathological ROS production while having limited impact on ROS in healthy cells, making it uniquely attractive as a potential MCM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynasore Analogues for Ocular Surface Protection
  • 批准号:
    10310762
  • 项目类别:
  • 资助金额:
    $10.87万
  • 财政年份:
    2019
  • 负责人:
    M. Elizabeth Fini
  • 依托单位:
Dynasore Analogues for Ocular Surface Protection
  • 批准号:
    10004039
  • 项目类别:
  • 资助金额:
    $22.33万
  • 财政年份:
    2019
  • 负责人:
    M. Elizabeth Fini
  • 依托单位:
Protection and Treatment of the Ocular Surface Barrier
  • 批准号:
    9334035
  • 项目类别:
  • 资助金额:
    $8.0万
  • 财政年份:
    2017
  • 负责人:
    M. Elizabeth Fini
  • 依托单位:
Discovery Approach to Ocular Hypertension
  • 批准号:
    9921393
  • 项目类别:
  • 资助金额:
    $59.29万
  • 财政年份:
    2017
  • 负责人:
    M. Elizabeth Fini
  • 依托单位:
海外基金